ALINITY I TOTAL PSA REAGENT KIT
Report
- Report Number
- 3008344661-2025-00076
- Event Type
- Malfunction
- Date Received
- May 28, 2025
- Date of Event
- May 13, 2025
- Report Date
- September 3, 2025
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Product Code
- MTF
- UDI-DI
- 00380740130442
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SP
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE COMPLAINT INVESTIGATION OF THE ALINITY I TOTAL PSA REAGENT LOT 72140FZ00 INCLUDED A REVIEW OF DATA AND INFORMATION PROVIDED BY THE CUSTOMER, SEARCH FOR SIMILAR COMPLAINTS, TICKET TRENDING REVIEW, LABELING REVIEW, AND DEVICE HISTORY RECORD REVIEW. DATA AND INFORMATION PROVIDED BY THE CUSTOMER WERE REVIEWED AND SUPPORT THE COMPLAINT ISSUE WITHOUT INDICATION FOR ANY ADDITIONAL ISSUE. A REVIEW OF TRACKING AND TRENDING DID IDENTIFY AN INCREASE IN COMPLAINTS FOR LIST NUMBER 07P92, HOWEVER, AN INCREASE IN COMPLAINT ACTIVITY FOR LOT 72140FZ00 WAS NOT IDENTIFIED. DEVICE HISTORY REVIEW DID NOT IDENTIFY ANY NON-CONFORMANCES OR DEVIATIONS WITH THE COMPLAINT LOT. LABELING WAS REVIEWED AND SUFFICIENTLY ADDRESSES THE CUSTOMER¿S ISSUE. BASED ON THE INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ALINITY I TOTAL PSA REAGENT LOT 72140FZ00 WAS IDENTIFIED.
AN EVALUATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. COMPLETED INFORMATION FOR SECTION A1 - PATIENT IDENTIFIER: SIDS (B)(6). ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 7P92-30, THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 7P92-21/-31, AND A 510K/PMA/BLA NUMBER P910007.
THE CUSTOMER OBSERVED FALSELY DECREASED ALINITY I TOTAL PSA RESULTS GENERATED FOR PATIENT SAMPLES. THE FOLLOWING DATA WAS PROVIDED: SAMPLE ID (B)(6) INITIAL RESULT = >1000 NG/ML, 1:15 MANUAL DILUTION RESULT = 520 NG/ML, 1:20 MANUAL DILUTION RESULT = 36 NG/ML. SAMPLE ID (B)(6) 1:15 MANUAL DILUTION RESULT = >1500 NG/ML, 1:20 MANUAL DILUTION RESULT = 72.8 NG/ML. BOTH SAMPLES WERE RETRIEVED AND PROCESSED WITH A 1:20 MANUAL DILUTION GENERATING THE EXPECTED RESULTS WHICH = 1724 NG/ML AND >2000 NG/ML. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
THE CUSTOMER OBSERVED FALSELY DECREASED ALINITY I TOTAL PSA RESULTS GENERATED FOR PATIENT SAMPLES. THE FOLLOWING DATA WAS PROVIDED: SAMPLE ID (B)(6); INITIAL RESULT = >1000 NG/ML, 1:15 MANUAL DILUTION RESULT = 520 NG/ML, 1:20 MANUAL DILUTION RESULT = 36 NG/ML. SAMPLE ID (B)(6); 1:15 MANUAL DILUTION RESULT = >1500 NG/ML, 1:20 MANUAL DILUTION RESULT = 72.8 NG/ML. BOTH SAMPLES WERE RETRIEVED AND PROCESSED WITH A 1:20 MANUAL DILUTION GENERATING THE EXPECTED RESULTS WHICH = 1724 NG/ML AND >2000 NG/ML. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 851131 | ALINITY I TOTAL PSA REAGENT KIT | TOTAL, PROSTATE SPECIFIC AG (NONCOMPLEXED/COMPLEXED) FOR DET OF PROSTATE CANCER | MTF | ABBOTT IRELAND DIAGNOSTICS DIVISION | 72140FZ00 | 00380740130442 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | ALNTY I PROCESSING MODU, 03R65-01, (B)(6).| ALNTY I PROCESSING MODU, 03R65-01, (B)(6). |